Smith Anglin Financial’s Elevance Health ELV Stock Holding History

Smith Anglin Financial’s Portfolio ELV Stock Details ELV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q4	–	Sell	-399	Closed	-$207K	–	218
2024 Q3	$207K	Hold	399	–	–	0.02%	193
2024 Q2	$216K	Sell	399 -41	-9%	-$21.7K	0.02%	175
2024 Q1	$228K	Hold	440	–	–	0.02%	169
2023 Q4	$208K	Sell	440 -98	-18%	-$45.3K	0.02%	170
2023 Q3	$234K	Buy	538 +16	+3%	+$7.26K	0.03%	152
2023 Q2	$232K	Buy	+522	New	+$241K	0.03%	149

Other funds holding ELV

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Sanders Capital West Palm Beach, Florida $83.9B AUM 37.89% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

First Eagle Investment Management New York $59B AUM 32.99% 1-Year Est. Return

Norges Bank Oslo, Norway $935B AUM

Smith Anglin Financial's ELV Position: Q4 2024 in Review

Smith Anglin Financial sold out of Elevance Health (ELV) in Q4 2024, closing a stake of 399 shares — an estimated $207K sold.

Smith Anglin Financial first reported a position in ELV in Q2 2023 and held it in 6 quarters. The position peaked at $234K in Q3 2023. 1,602 funds tracked by Wall St. Rank hold ELV as of Q4 2024.

Smith Anglin Financial reported no remaining Elevance Health position as of Q4 2024 after selling out during the quarter.
Smith Anglin Financial sold 399 Elevance Health shares in Q4 2024, an estimated $207K.
Smith Anglin Financial first reported a position in Elevance Health in Q2 2023 and held it in 6 quarters.
Smith Anglin Financial's Elevance Health position peaked at $234K in Q3 2023.
1,602 funds tracked by Wall St. Rank held Elevance Health as of Q4 2024.

Based on Smith Anglin Financial's 13F filing for Q4 2024, filed 14 Jan 2025.